Jul 26, 2021 / 11:00AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Alembic Pharmaceuticals Limited to discuss the company's Q1 FY '22 financial results. We have with us today from the management, Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director, Mr. R.K. Baheti, Director Finance and CFO; Mr. Mitanshu Shah, Head Finance; Mr. Jesal Shah, Head Strategy; and Mr. Ajay Kumar Desai, Senior VP, Finance. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. R.K. Baheti, Director Finance and CFO, from Alembic Pharmaceuticals Limited. Thank you, and over to you, sir.
Raj Kumar Shreeram Baheti - Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director
Thank you. Good evening, everyone. Thank you for joining the first quarter results conference call. I'm sure you would have got the results by now. However, let me briefly take you through the numbers for the quarter ended 30th June 2021.
During the quarter, our total revenue was flat at INR 1,326 crores -- INR 1
Q1 2022 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Jul 26, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers